JP Morgan
JP Morgan Downgrades NanoString Technologies to Neutral
The downgrade follows a Delaware jury's recent finding that NanoString's GeoMx Digital Spatial Profiler infringes seven patents held by 10x Genomics.
Hologic Aims to Expand Global Reach With Focus on Women's Health
At the JP Morgan Healthcare conference, CEO Steve MacMillan especially noted Africa as an underserved market for women's health.
PerkinElmer Becoming Pure Play Dx, Life Science Firm, Spurred on by COVID Innovations
At the JP Morgan conference, the firm's CEO said that it chose to divest its applied, food, and enterprise businesses due to innovations it achieved during the pandemic.
The company is planning to launch a 4-in-1 prenatal screening test, a liquid biopsy test, and a minimal residual disease assay in the coming year.
Morgan Health Invests $20M in LetsGetChecked
Morgan Health CEO Dan Mendelson said that the investment was in line with the business unit's focus on employee health.
Aug 11, 2022
JP Morgan Downgrades Seer to Neutral
Aug 25, 2021
PerkinElmer Reaches Deal for $1.5B Credit Facility
Aug 12, 2021
PerkinElmer Enters $500M Credit Facility
May 24, 2021
Singular Genomics Ups IPO Target to $187M
Dec 2, 2020